Episode 14: Clinical Trial Challenges in the COVID-19 Pandemic
A. Kate MacDougall
Nataya Francis, ARNP
As more and more clinical trials begin analyzing the novel SARS-CoV-2 virus and the efficacy and safety of potential treatment options, many of us are left wondering about how this shift in focus will affect ongoing and future clinical trials for other diseases, especially cancer. Nataya Francis, ARNP, nurse practitioner in the Clinical Research Unit at Moffitt Cancer Center, is seeing the impact on the oncology clinical trials management process firsthand.
Read our coverage on our Society website.